CTOs on the Move

Floyd Medical Center

www.floydmed.org

 
Floyd Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Floyd Medical Center is based in Rome, GA. You can find more information on Floyd Medical Center at www.floydmed.org
  • Number of Employees: 5K-10K
  • Annual Revenue: $500M-1 Billion
  • www.floydmed.org
  • 304 Turner Mccall Blvd SW
    Rome, GA USA 30165
  • Phone: 706.509.5000

Executives

Name Title Contact Details

Similar Companies

Swan Hospice

Swan Hospice is a healthcare provider that offers personalized end-of-life care plans for terminally ill adult patients and support for their families.

Integrated Health Plan Inc

Integrated Health Plan Inc is a Saint Petersburg, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Essex Group Management

Essex Group Management is a Milford, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Access Integrated Healthcare

Founded by Chief Executive Officer Sam Solakyan, Global Holdings, Inc. has excelled in its journey in becoming leaders in each of the industries it has a presence in. Their main responsibility lies in providing their clients with the most premiere level of service. More than just your typical holdings group, Global is a multifaceted company with financial assets and ownership in the radiology, pharmaceuticals, and medical billing and collections industries. Instead of merely buying and selling companies like other holdings groups, Global searches for the less desirable companies with hidden potential and applies its knowledge and expertise in the management field and aids in the recreation of a company that once was not.

Fibrocell Science

Making an impact on rare and serious skin and connective tissue diseases Fibrocell Science is at the forefront of the exciting and promising field of personalized biologics. By extracting cells from skin to create localized therapies that are compatible with the unique biology of each patient, personalized biologics bring a transformational approach to drug development. It is Fibrocell’s scientific leadership and legacy in cultivating and harnessing autologous fibroblast cells that fuels its personalized biologics approach. Fibrocell’s proprietary technology uses a person’s own fibroblast cells – with or without genetic modification – to target localized treatment of rare and serious skin and connective tissue diseases.